Lenvatinib, Pembrolizumab Combo Shows Promising Results in Metastatic RCC

Treatment with lenvatinib and pembrolizumab has shown promise in patients with metastatic clear cell renal cell carcinoma who have already received an immune checkpoint inhibitor.

Source: CancerNetwork - November 5, 2019 Category: Cancer & Oncology Authors: Seth Augenstein Source Type: news